Le Lézard
Classified in: Health, Business
Subjects: MUTUAL FUNDS, v

Healthcare Special Opportunities Fund Announces Special Distribution for the year 2020


NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

TORONTO, Dec. 16, 2020 (GLOBE NEWSWIRE) -- (TSX: MDS.UN) ? LDIC Inc. (the "Manager"), the manager of Healthcare Special Opportunities Fund (the "Fund"), a closed-end investment fund, today announces the special distribution of CDN$0.19124 per Class A unit. The special distribution will be paid in cash on or before December 31, 2020 to unitholders of record on December 23, 2020.

For further information please contact:

LDIC Inc.
Tel: (416) 362-4141
Email: [email protected]
Website: www.ldic.ca



These press releases may also interest you

at 10:45
Fast-Growing Prior Authorization Software Company Announces Addition of Chief Revenue Officer
eBlu Solutions, a leading provider of innovative technology solutions for the specialty healthcare industry, is pleased to announce the addition of Doug Lawrence to the Executive Leadership team in the role of Chief Revenue Officer. "We're not just...

at 09:18
NUVISTA Mental Health Joins As Gold Sponsors For 2024 First Responders Mental Health Conference
NUVISTA Mental Health proudly announces its participation as a Gold Sponsor for the 2024 Ontario First...

at 09:05
Cardurion Pharmaceuticals Presents Positive Clinical Results from CARDINAL?HF Phase 2a Clinical Trial of PDE9 Inhibitor in Patients With Heart Failure
Cardurion Pharmaceuticals, Inc. ("Cardurion"), a clinical-stage biotechnology company developing next-generation therapeutics for the treatment of cardiovascular diseases, today announced the presentation of positive clinical data from CARDINAL?HF,...

at 06:05
KFSH&RC Strives to Pioneer in Maximizing Healthcare Spending Value
Dr. Majid Al Fayyadh, CEO of King Faisal Specialist Hospital and Research Centre (KFSH&RC) joined the Gulf Creatives Conference (GCC) at Harvard 2024. The event, GCC at Harvard, is organized by The Diwan, an organization run by graduate students at...

at 06:00
Replicate Bioscience Presents Positive Data from Phase 1 Trial and Preclinical Data with Novel Self-Replicating RNA at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology for use across a range of infectious disease, oncology,...

at 03:14
Caliway to Present the Latest Clinical Advancements at 2024 BIO International Convention
Caliway Biopharmaceuticals (Caliway) is pleased to announce its participation to share the latest clinical advancements at the upcoming 2024 BIO International Convention on Wednesday, June 5th, at 11:45 a.m. PDT. The presentation will take place in...

More news about Health...


News published on and distributed by: